Related Experiment Video
Updated: Feb 17, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Delta/notch-like epidermal growth factor-related receptor (DNER) orchestrates stemness and cancer progression in
Lijun Wang1, Qi Wu1, Shan Zhu1
1Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan UniversityWuhan, Hubei, P. R. China.
Abstract:
DNER, Delta/Notch-like epidermal growth factor (EGF)-related receptor, is a neuron-specific transmembrane protein carrying extracellular EGF-like repeats. The function of DNER in prostate cancer has not been evaluated. Here, we showed that the upregulation of DNER is observed in various cancers, including prostate cancer. Knockdown of DNER in PC-3 cells inhibited cell proliferation, migration and invasion as well as tumorigenesis in PC-3 xenografts. DNER knockdown specifically inhibited cell growth in spheroids. RT-PCR and western blot analysis were performed, and CD44, HES1 and GLI1 expression was significantly decreased in DNER knockdown cells. Thus, DNER promotes prostate cancer progression and the growth of PC-3 cells by modulating the primary genes of cancer stem cells.
Insights
Delta/Notch-like epidermal growth factor (EGF)-related receptor (DNER) upregulation promotes prostate cancer progression. Inhibiting DNER in PC-3 cells reduced cancer cell growth, migration, invasion, and tumorigenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Delta/Notch-like epidermal growth factor (EGF)-related receptor (DNER) is a neuron-specific transmembrane protein.
- The role of DNER in prostate cancer has not been previously investigated.
Purpose of the Study:
- To investigate the function of DNER in prostate cancer progression.
- To determine the mechanism by which DNER influences prostate cancer cell growth and characteristics.
Main Methods:
- Upregulation of DNER was assessed in various cancer types, including prostate cancer.
- DNER was knocked down in PC-3 prostate cancer cells.
- Cell proliferation, migration, invasion, and spheroid growth were evaluated.
- Gene expression analysis (RT-PCR and Western blot) was performed for key cancer stem cell markers (CD44, HES1, GLI1).
- Tumorigenesis was assessed in PC-3 xenograft models.
Main Results:
- DNER expression was found to be upregulated in prostate cancer.
- Knockdown of DNER significantly inhibited PC-3 cell proliferation, migration, and invasion.
- DNER knockdown suppressed tumor growth in xenograft models and cell growth in spheroids.
- The expression of CD44, HES1, and GLI1 was significantly decreased in DNER knockdown cells.
Conclusions:
- DNER plays a crucial role in promoting prostate cancer progression.
- DNER facilitates prostate cancer cell growth, migration, and invasion.
- DNER modulates key cancer stem cell genes, contributing to prostate cancer development.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mitogens and the Cell Cycle
Stem Cell Niche
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Canonical Wnt Signaling Pathway